|
CN112062888A
|
|
Preparation method of extra-strong acidic cation exchange resin
|
|
CN112090454A
|
|
Macroporous weakly-alkaline styrene anion exchange resin method and equipment thereof
|
|
CN112062893A
|
|
Method and equipment for macroporous weak-acid cation exchange resin
|
|
CN112062887A
|
|
Macroporous strong-alkaline anion exchange resin method and equipment
|
|
CN110257112A
|
|
A kind of preparation method of strong anti-knock properties ethers fuel oil
|
|
CN110257110A
|
|
It is a kind of based on dimethyl ether be raw material vehicle fuel
|
|
CN110257111A
|
|
It is a kind of based on two n-pentyl ethers be raw material ethers fuel oil
|
|
CN104892731A
|
|
Synthetic method of oxytocin peptides
|
|
CN105131038A
|
|
TAF(tenofovir alafenamide fumarate) preparation method
|
|
CN104906062A
|
|
Sofosbuvir tablet and preparation method thereof
|
|
CN104926909A
|
|
Preparation method for obeticholic acid
|
|
CN105001173A
|
|
Preparation method of LZ969
|
|
CN104860936A
|
|
Rivaroxaban preparation method
|
|
CN104803991A
|
|
Preparation method and application of rivaroxaban intermediate (S)-N-epoxy propyl phthalimide
|
|
CN104910141A
|
|
Preparation method for Rivaroxaban intermediate 5-chloro-N-(2-oxiranylmethyl)-2-thiophene methanamide
|
|
CN104788444A
|
|
Preparation method of rivaroxaban
|
|
CN104829551A
|
|
Method for preparing rivaroxaban midbody 4-(4-aminophenyl)-3-morpholone
|
